Peptide-based assemblies as immune checkpoint inhibitor delivery systems for enhanced immunotherapy

Published on Jun 1, 2021in Applied Materials Today8.352
· DOI :10.1016/J.APMT.2021.101063
Zhenwei Deng1
Estimated H-index: 1
(Ocean University of China),
Cong-Shan Yuan1
Estimated H-index: 1
(Ocean University of China)
+ 2 AuthorsYa Liu21
Estimated H-index: 21
(Ocean University of China)
Source
Abstract
Abstract In recent years, with the continuous development of cancer immunotherapy, the strategy of human beings against cancer has undergone tremendous changes. Among them, immune checkpoint inhibitors based on the immune "brake" mechanism, as an indispensable part of immunotherapy, have brought new dawn to cancer treatment. Humans have developed a variety of monoclonal antibodies against CTLA-4 and PD-1/PD-L1, which have shown significant therapeutic effects on various cancers, especially melanoma. Several monoclonal antibodies have been approved for clinical treatment and obtained exciting clinical benefits. However, immune checkpoint therapy is still plagued by two shortcomings: low response rate and high side effects. Polypeptides have broad application prospects in the field of drug delivery due to their low immunogenicity, low toxicity and versatility. Peptide-based assemblies with specificity and safety can be used for targeted delivery of immune checkpoint inhibitors. Strategies such as PEG modification and “reassembly in vivo” can effectively increase the response rate of immune checkpoint inhibitors and reduce side effects. This review introduces multiple types of immune checkpoints and peptide-based assemblies for immune checkpoint inhibitor delivery, and the roles of peptides in these assembles are described in detail. The synergistic effect of immune checkpoint blockade and other therapies to enhance antitumor immunotherapy is emphasized.
References126
Newest
#1Hiroaki WakiyamaH-Index: 4
#2Aki FurusawaH-Index: 7
Last. Hisataka KobayashiH-Index: 11
view all 8 authors...
Near-infrared photoimmunotherapy (NIR-PIT) is a highly selective cancer treatment that employs an antibody photoabsorber conjugate (APC) composed of a targeting monoclonal antibody (mAb) conjugated with a photoactivatable phthalocyanine-derivative dye. Once injected and allowed to bind to a tumor, the APC is activated by local near-infrared light which kills cancer cells and induces a strong immune response in the tumor microenvironment by unmasking of new tumor antigens emerging from damaged tu...
5 CitationsSource
#1Zili Gu (LUMC: Leiden University Medical Center)H-Index: 1
#2Candido G. Da Silva (LUMC: Leiden University Medical Center)H-Index: 2
Last. Luis J. Cruz (LUMC: Leiden University Medical Center)H-Index: 29
view all 5 authors...
Cancer immunotherapy has shown remarkable progress in recent years. Nanocarriers, such as liposomes, have favorable advantages with the potential to further improve cancer immunotherapy and even stronger immune responses by improving cell type-specific delivery and enhancing drug efficacy. Liposomes can offer solutions to common problems faced by several cancer immunotherapies, including the following: (1) Vaccination: Liposomes can improve the delivery of antigens and other stimulatory molecule...
7 CitationsSource
#1Zhenwei DengH-Index: 1
#2Ting WangH-Index: 5
Last. Ya Liu (Ocean University of China)H-Index: 21
view all 4 authors...
Marine-derived chitosan has been widely examined for its use in developing biomedical materials. Not only is it non-toxic, biocompatible, and degradable, it has also shown unique antimicrobial properties. The antimicrobial properties of chitosan are restricted by neutral and physiological conditions because it is insoluble in water and its pKa values is 6.5. One solution to this problem is to graft chemically modified groups onto the backbone of chitosan. The aim of this paper is to review the m...
11 CitationsSource
#1Yasuhiro MaruokaH-Index: 13
#2Aki FurusawaH-Index: 7
Last. Hisataka KobayashiH-Index: 80
view all 10 authors...
Near infrared photoimmunotherapy (NIR-PIT) is a newly developed and highly selective cancer treatment that induces necrotic/immunogenic cell death. It employs a monoclonal antibody (mAb) conjugated to a photo-absorber dye, IRDye700DX, which is activated by NIR light. Tumor-targeting NIR-PIT is also at least partly mediated by a profound immune response against the tumor. Cytotoxic T-lymphocyte antigen-4 (CTLA4) is widely recognized as a major immune checkpoint protein, which inhibits the immune ...
7 CitationsSource
#1Ling Li (NIH: National Institutes of Health)H-Index: 11
#2Zhen Yang (NIH: National Institutes of Health)H-Index: 35
Last. Xiaoyuan Chen (NIH: National Institutes of Health)H-Index: 162
view all 3 authors...
ConspectusImmunotherapy has attracted significant interest because of its tremendous potential in cancer therapy. The recent advances in the identification of cancer-associated neoantigens, chimeric antigen receptor (CAR) T-cell and immune checkpoint blockade (ICB), have revolutionized the field of cancer immunotherapy. Cancer immunotherapeutic agents typically exhibit strong immune activation or inhibition activity, thereby inducing robust biological effect even when administered at a small dos...
19 CitationsSource
#5Muhetaerjiang Mamuti (Center for Excellence in Education)H-Index: 2
#8Wanhai Xu (HMU: Harbin Medical University)H-Index: 17
Last. Hao Wang (Center for Excellence in Education)H-Index: 108
view all 10 authors...
One of the major challenges of immune checkpoint blockade (ICB) is the poor penetration of antibody for solid tumor treatment. Herein, peptides with deeper penetration capability are used to develop a click reaction-assisted peptide immune checkpoint blockade (CRICB) strategy that could in situ construct assemblies, enabling enhanced accumulation and prolonged PD-L1 occupancy, ultimately realizing high-performance tumor inhibition. First, the free DBCO-modified targeting peptide (TP) efficiently...
7 CitationsSource
#1Cong-Shan Yuan (Ocean University of China)H-Index: 1
#2Ya Liu (Ocean University of China)H-Index: 21
Last. Xiguang Chen (Ocean University of China)H-Index: 61
view all 5 authors...
Immunomodulatory therapeutics, which is conducive to overcoming tumor tolerance and restoring normal immune responses, has been proposed as a promising approach for enhanced cancer therapy and clin...
8 CitationsSource
#1Liang Chen (Sichuan University)H-Index: 4
#2Weihua Zhuang (Sichuan University)H-Index: 12
Last. Yunbing Wang (Sichuan University)H-Index: 17
view all 8 authors...
Nanocarriers have been an important strategy for enhancing the combination therapy of chemotherapy and photodynamic therapy (PDT) (Chem-PDT). However, conventional nanocarriers suffer from the problems of drug leakage in blood and insufficient drug release at target sites. Herein, we have designed a chlorin e6 (Ce6)-loaded GEM prodrug polymer micelle with a singlet oxygen cleavable linker and a pH responsive switch to avoid drug leakage in blood. These Ce6-loaded prodrug micelles possessed a uni...
6 CitationsSource
#1Gwendolyn M. Cramer (UPenn: University of Pennsylvania)H-Index: 6
#2Edmund K. Moon (UPenn: University of Pennsylvania)H-Index: 24
Last. Theresa M. Busch (UPenn: University of Pennsylvania)H-Index: 33
view all 4 authors...
Immune checkpoints including PD-1 and CTLA-4 help to regulate the intensity and timeframe of the immune response. Since they become upregulated in cancer and prevent sufficient anti-tumor immunity, monoclonal antibodies against these checkpoints have shown clinical promise for a range of cancers. Multimodal treatment plans combining immune checkpoint inhibitors with other therapies, including photodynamic therapy (PDT), may help to expand treatment efficacy and minimize side effects. PDT's cytot...
11 CitationsSource
#1Danfeng Wei (Sichuan University)H-Index: 1
#2Ze Tao (Sichuan University)H-Index: 7
Last. Xian Jiang (Sichuan University)H-Index: 9
view all 12 authors...
Antibody-based near-infrared photoimmunotherapy (NIR-PIT) is an attractive strategy for cancer treatment. Tumor cells can be selectively and efficiently killed by the targeted delivery of an antibo...
7 CitationsSource
Cited By0
Newest